Shareholders’ Equity - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Number of Shares
Outstanding at beginning of period (in shares)	10,243,772
Exercised (in shares)	(28,663)
Forfeited or expired (in shares)	(24,708)
Outstanding at end of period (in shares)	10,190,401	10,243,772
Options vested and exercisable (in shares)	8,476,816
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in usd per share)	$ 6.43
Exercised (in usd per share)	1.59
Forfeited or expired (in usd per share)	15.22
Weighted average exercise price, ending balance (in usd per share)	6.42	$ 6.43
Options vested and exercisable (in usd per share)	$ 5.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Total Intrinsic Value	$ 1,128	$ 1,956
Options vested and exercisable, intrinsic value	$ 1,128
Weighted Average Remaining Contractual Life (Years)	5 years 9 months 18 days	6 years
Options vested and exercisable, weighted average remaining contractual term	5 years 6 months
Market and service condition based options
Number of Shares
Outstanding at beginning of period (in shares)	4,453,297
Outstanding at end of period (in shares)	4,453,297	4,453,297
Options vested and exercisable (in shares)	3,536,630
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in usd per share)	$ 12.75
Weighted average exercise price, ending balance (in usd per share)	12.75	$ 12.75
Options vested and exercisable (in usd per share)	$ 10.98
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Total Intrinsic Value	$ 0	$ 0
Options vested and exercisable, intrinsic value	$ 0
Weighted Average Remaining Contractual Life (Years)	4 years 4 months 24 days	4 years 8 months 12 days
Options vested and exercisable, weighted average remaining contractual term	4 years 2 months 12 days